Key Benefits:

Weight management

The new oral GLP-1 pill supports chronic weight loss through appetite suppression and reduced calorie intake

Metabolic support

Improves glucose control, insulin sensitivity, and overall metabolic function

Energy and vitality

Helps stabilise blood sugar levels for consistent energy and reduced cravings

Body composition

Promotes fat loss while preserving lean muscle within our structured weight loss program

Foundayo

Price range: AED 773 through AED 1,599

Prescription Required:

After you place your order, our customer care team will contact you immediately (for orders placed before 5 PM) to book your appointment with our doctor.

Cash on delivery
free express delivery
Delivery in dubai only
This purchase unlocks free access to our insurance-covered weight loss program, you don't have to pay anything extra:
Description

After you join the waitlist, our customer care team will contact you to schedule your in-clinic consultation. Foundayo is a next-generation oral GLP-1 therapy designed for chronic weight management and metabolic health. Unlike injectable GLP-1 medications, Foundayo is taken as a daily pill, offering a more convenient, stigma-free option for long-term use. Stock is expected to arrive by April 28th. An in-clinic doctor consultation is mandatory, after which the medication can be delivered to your home.

Additional info:

Foundayo works by mimicking the body’s natural GLP-1 (glucagon-like peptide-1) hormone, an essential regulator of appetite, insulin secretion, and blood sugar balance. It slows gastric emptying, reduces hunger signals in the brain, and improves insulin response after meals.
In individuals with obesity, insulin resistance, or metabolic dysfunction, GLP-1 signalling is often impaired leading to increased appetite, poor glucose control, and gradual weight gain. As an oral GLP-1 therapy, Foundayo helps restore this pathway in a more accessible format, supporting sustainable weight loss, improved metabolic markers, and better long-term adherence due to its pill-based delivery.